Iain Livingstone1,2, Laura Butler3, Esther Misanjo4,5, Alan Lok3,6, Duncan Middleton7, Janice Waterson Wilson8, Silvija Delfin9, Petros Kayange4,5, Ruth Hamilton8,10. 1. Falkirk Community Hospital, NHS Forth Valley, Falkirk, UK. 2. Glasgow Centre for Ophthalmic Research, NHS Greater Glasgow and Clyde, Glasgow, UK. 3. Tennent Institute of Ophthalmology, Gartnavel General Hospital, NHS Greater Glasgow and Clyde, Glasgow, UK. 4. Lions First Sight Eye Unit, Queen Elizabeth University Hospital, Blantyre, Malawi. 5. Ophthalmology Department, College of Medicine, University of Malawi, Blantyre, Malawi. 6. University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK. 7. Medical Devices Unit, West Glasgow Ambulatory Care Hospital, NHS Greater Glasgow and Clyde, Glasgow, UK. 8. Royal Hospital for Children, NHS Greater Glasgow and Clyde, Glasgow, UK. 9. Inverclyde Royal Hospital, NHS Greater Glasgow and Clyde, Greenock, UK. 10. College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.
Abstract
PURPOSE: To evaluate two builds of the digital grating acuity test, "Peekaboo Vision" (PV), in young (6-60 months) populations in two hospital settings (Malawi and United Kingdom). METHODS: Study 1 evaluated PV in Blantyre, Malawi (N = 58, mean age 33 months); study 2 evaluated an updated build in Glasgow, United Kingdom (N = 60, mean age 44 months). Acuities were tested-retested with PV and Keeler Acuity Cards for Infants (KACI). Bland-Altman techniques were used to compare results and repeatability. Child engagement was compared between groups. Study 2 included test-time comparison. RESULTS: Study 1 (Malawi): The mean difference between PV and KACI was 0.02 logMAR with 95% limits of agreement (LoA) of 0.33 to 0.37 LogMAR. On test-retest, PV demonstrated 95% LoA of -0.283 to 0.198 logMAR with coefficient of repeatability (CR) 0.27. KACI demonstrated 95% LoA of -0.427 to 0.323 logMAR, and larger CR was 0.37. PV evidenced higher engagement scores than KACI (P = 0.0005). Study 2 (UK): The mean difference between PV and KACI was 0.01 logMAR; 95% LoA was -0.413 to 0.437 logMAR. Again, on test-retest, PV had narrower LoA (-0.344 to 0.320 logMAR) and lower CR (0.32) versus KACI, with LoA -0.432 to 0.407 logMAR, CR 0.42. The two tests did not differ in engagement score (P = 0.5). Test time was ∼1 minute shorter for PV (185 vs. 251 s, P = 0.0021). CONCLUSIONS: PV gives comparable results to KACI in two pediatric populations in two settings, with benefits in repeatability indices and test duration. TRANSLATIONAL RELEVANCE: Leveraging tablet technology extends reliable infant acuity testing to bedside, home, and rural settings, including areas where traditional equipment cannot be financed.
PURPOSE: To evaluate two builds of the digital grating acuity test, "Peekaboo Vision" (PV), in young (6-60 months) populations in two hospital settings (Malawi and United Kingdom). METHODS: Study 1 evaluated PV in Blantyre, Malawi (N = 58, mean age 33 months); study 2 evaluated an updated build in Glasgow, United Kingdom (N = 60, mean age 44 months). Acuities were tested-retested with PV and Keeler Acuity Cards for Infants (KACI). Bland-Altman techniques were used to compare results and repeatability. Child engagement was compared between groups. Study 2 included test-time comparison. RESULTS: Study 1 (Malawi): The mean difference between PV and KACI was 0.02 logMAR with 95% limits of agreement (LoA) of 0.33 to 0.37 LogMAR. On test-retest, PV demonstrated 95% LoA of -0.283 to 0.198 logMAR with coefficient of repeatability (CR) 0.27. KACI demonstrated 95% LoA of -0.427 to 0.323 logMAR, and larger CR was 0.37. PV evidenced higher engagement scores than KACI (P = 0.0005). Study 2 (UK): The mean difference between PV and KACI was 0.01 logMAR; 95% LoA was -0.413 to 0.437 logMAR. Again, on test-retest, PV had narrower LoA (-0.344 to 0.320 logMAR) and lower CR (0.32) versus KACI, with LoA -0.432 to 0.407 logMAR, CR 0.42. The two tests did not differ in engagement score (P = 0.5). Test time was ∼1 minute shorter for PV (185 vs. 251 s, P = 0.0021). CONCLUSIONS: PV gives comparable results to KACI in two pediatric populations in two settings, with benefits in repeatability indices and test duration. TRANSLATIONAL RELEVANCE: Leveraging tablet technology extends reliable infant acuity testing to bedside, home, and rural settings, including areas where traditional equipment cannot be financed.
Entities:
Keywords:
grating acuity; mobile technology; tablet computer
Authors: Tariq M Aslam; Ian J Murray; Michael Y T Lai; Emma Linton; Humza J Tahir; Neil R A Parry Journal: J R Soc Interface Date: 2013-05-08 Impact factor: 4.118
Authors: Kathleen M Mohan; Joseph M Miller; Erin M Harvey; Kimberly D Gerhart; Howard P Apple; Deborah Apple; Jordana M Smith; Amy L Davis; Tina Leonard-Green; Irene Campus; Leslie K Dennis Journal: J Pediatr Ophthalmol Strabismus Date: 2016 Jan-Feb Impact factor: 1.402
Authors: Pete R Jones; Sarah Kalwarowsky; Janette Atkinson; Oliver J Braddick; Marko Nardini Journal: Invest Ophthalmol Vis Sci Date: 2014-10-28 Impact factor: 4.799
Authors: Guillermo Vivas-Mateos; Iain A T Livingstone; Ruth Hamilton; Arsalan Cheema; Mario E Giardini Journal: Transl Vis Sci Technol Date: 2020-11-06 Impact factor: 3.283